Advertisement
Advertisement
SEER
Seer, Inc. Class A Common Stock
1.61
USDSponsored
-0.07
-4.17%
Nov 10, 15:59 UTC -5
Closed
After-Market
1.60
-0.01
-0.31%
Seer, Inc. Class A Common Stock (SEER) Earnings
SEER Earnings Reports
Positive Surprise Ratio
SEER beat 16 of 24 last estimates.
67%
Next Report
Date of Next Report
Feb 24, 2027
Estimate for Q4 26 (Revenue/ EPS)
$6.22M
/-$0.22
Implied change from Q3 26 (Revenue/ EPS)
+56.33%
/-12.00%
Implied change from Q4 25 (Revenue/ EPS)
+48.11%
/-21.43%
Seer, Inc. Class A Common Stock earnings per share and revenue
On Nov 10, 2026, SEER reported earnings of -0.25 USD per share (EPS) for Q3 26, beating the estimate of -0.25 USD, resulting in a 1.96% surprise. Revenue reached 3.98 million, compared to an expected 4.23 million, with a -5.98% difference.
Looking ahead to Q4 26, 3 analysts forecast an EPS of -0.22 USD, with revenue projected to reach 6.22 million USD, implying an decrease of -12.00% EPS, and increase of 56.33% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Kura Oncology, Inc.
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.83
Actual
-$0.78
Surprise
+7.00%
Olema Pharmaceuticals, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.63
Actual
-$0.73
Surprise
-14.53%
Autolus Therapeutics plc - ADR
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.16
Actual
-$0.21
Surprise
-27.20%
Protalix BioTherapeutics, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.03
Actual
$0.05
Surprise
+265.02%
PepGen Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.27
Actual
-$0.28
Surprise
-1.19%
Humacyte, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.07
Surprise
+22.91%
Scholar Rock Holding Corporation Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.86
Actual
-$0.81
Surprise
+6.18%
TELA Bio, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.16
Actual
-$0.13
Surprise
+20.54%
Atossa Therapeutics, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.90
Actual
-$0.56
Surprise
+38.31%
CalciMedica, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$1.30
Actual
-$0.72
Surprise
+44.64%
FAQ
What were Seer, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Seer, Inc. Class A Common Stock reported EPS of -$0.25, beating estimates by 1.96%, and revenue of $3.98M, -5.98% below expectations.
How did the market react to Seer, Inc. Class A Common Stock's Q3 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Seer, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Feb 24, 2027.
What are the forecasts for Seer, Inc. Class A Common Stock's next earnings report?
Based on 3
analysts, Seer, Inc. Class A Common Stock is expected to report EPS of -$0.22 and revenue of $6.22M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.